Skip to main content
Figure 8 | Lipids in Health and Disease

Figure 8

From: Time course-changes in phosphatidylcholine profile during oxidative modification of low-density lipoprotein

Figure 8

Immunoreativity of human oxLDL to antibodies against oxPC and apoB. Human LDL (0.2 mg/mL) treated either with or without a PAF-AH inhibitor, pefabloc, was incubated with copper sulfate (5 μM) at 37°C for up to 3 h. Oxidative changes of immunoreactivity by sandwich ELISA using antibodies against oxPC and apoB were evaluated. Relative immunoreactivity was calculated from 10 experiments. Statistical significance between samples with and without pefabloc treatment was calculated by Welch t-test; *, p < 0.05.

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X